*Actual vial appearance, contents, and dosage may vary and is based on your prescription.
PT-141 has been studied for its action on melanocortin receptors in the hypothalamus and limbic system, which are involved in sexual motivation and arousal signaling.
https://pubmed.ncbi.nlm.nih.gov/17009063/
Unlike PDE-5 inhibitors, PT-141 does not rely on vascular dilation mechanisms, making it mechanistically distinct in the scientific literature.
https://pubmed.ncbi.nlm.nih.gov/21427119/
Clinical research has evaluated intranasal PT-141 in male and female populations for effects related to sexual desire and arousal under controlled conditions.
https://pubmed.ncbi.nlm.nih.gov/19887552/
Intranasal administration has been explored for its ability to deliver neuroactive compounds that influence central signaling pathways.
https://pubmed.ncbi.nlm.nih.gov/26140940/
Research suggests PT-141 may be relevant in contexts where sexual concerns are influenced by central or psychogenic factors rather than purely vascular causes.
https://pubmed.ncbi.nlm.nih.gov/21427119/
PT-141 nasal spray is prescribed by licensed healthcare providers based on an individual clinical evaluation and medical eligibility. Compounded nasal formulations are not FDA-approved, and their safety and effectiveness have not been independently evaluated by the FDA.
This information is provided for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.
Information provided is for educational purposes only and does not constitute medical advice. All care and prescriptions are provided solely at the discretion of a licensed healthcare provider following an individual evaluation.
Below are peer-reviewed studies and authoritative publications related to PT-141 and intranasal administration:
Hear from individuals who chose a more guided, informed approach to their wellness journey.
A Celara Med User
A Celara Med User
Quick answers to common questions, designed to help you feel clear and confident as you explore Celara Med.
No. This formulation is a nasal spray, not an injection. While the active compound is the same, absorption, onset, and dosing protocols differ.
PT-141 nasal spray works through central melanocortin receptor signaling in the brain, influencing sexual desire and arousal pathways rather than blood-flow mechanisms.
https://pubmed.ncbi.nlm.nih.gov/28778618/
No. PT-141 is not a hormone and does not affect testosterone or estrogen levels.
Adults experiencing concerns related to sexual desire or arousal signaling may be evaluated by a licensed healthcare provider. Eligibility is determined through individual clinical review.
Some individuals may experience temporary effects such as nasal irritation, headache, flushing, nausea, or mild increases in blood pressure. Side effects vary and should be discussed with a provider.
In some cases, a provider may approve PT-141 nasal spray alongside other sexual-health–focused or wellness therapies, depending on individual needs and clinical appropriateness.
PT-141 nasal spray through Celara Med is available in 48 states, excluding Alabama and Mississippi, subject to state regulations and provider licensure.
Yes. PT-141 nasal spray is offered within a structured care plan designed to support appropriate use, monitoring, and clinical oversight.
Explore other provider-guided options that may better align with your goals.
Tadalafil is a phosphodiesterase type-5 (PDE-5) inhibitor that has been extensively studied for its role in vascular smooth muscle relaxation…
PT-141, also known as bremelanotide, is a synthetic peptide derived from melanocortin receptor research. Unlike therapies that act primarily on…